We are live on ! Find out more

576 hedge funds and large institutions have $11.4B invested in Sanofi in 2021 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 219 increasing their positions, 171 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

366% more call options, than puts

Call options by funds: $110M | Put options by funds: $23.6M

28% more repeat investments, than reductions

Existing positions increased: 219 | Existing positions reduced: 171

7% more capital invested

Capital invested by funds: $10.7B → $11.4B (+$736M)

2.66% more ownership

Funds ownership: 16.06%18.72% (+2.7%)

4% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 56

2% less funds holding

Funds holding: 585576 (-9)

29% less funds holding in top 10

Funds holding in top 10: 75 (-2)

Holders
576
Holders Change
-9
Holders Change %
-1.54%
% of All Funds
10.08%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.09%
New
54
Increased
219
Reduced
171
Closed
56
Calls
$110M
Puts
$23.6M
Net Calls
+$86.5M
Net Calls Change
+$65.1M

SNY Hedge Fund Activity: Q3 2021 in Review

576 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2021, worth a combined $11.4B — up 6.9% from $10.7B a quarter earlier.

Sellers outnumbered buyers: 56 funds closed out of SNY and 54 opened new positions — a net loss of 2 holders — while 171 trimmed existing stakes and 219 added.

The largest buyer was Dodge & Cox, adding an estimated $1.21B. The largest seller was BlackRock, cutting an estimated $26.1M.

  • 576 institutional investors held Sanofi (SNY) as of Q3 2021, down from 585 in Q2 2021.
  • Funds reported $11.4B of Sanofi stock for Q3 2021, up 6.9% quarter-over-quarter.
  • 54 funds opened new Sanofi positions in Q3 2021 and 56 closed out, a net change of -2 holders.
  • The largest Sanofi buyer in Q3 2021 was Dodge & Cox, an estimated $1.21B added.
  • The largest Sanofi seller in Q3 2021 was BlackRock, an estimated $26.1M sold.

Based on aggregated 13F filings for Q3 2021.